Reprinted from Proc. Natl. Acad. Sci. USA Vol. 74, No. 4, pp. 1680-1682, April 1977 Genetics Replication and expression of plasmids from Staphylococcus aureus in Bacillus subtilis (DNA/genetic transformation/molecular cloning/biohazards) S. D. EHRLICH* Department of Genetics, Stanford University Medical School, Stanford, California 94305 Communicated by Joshua Lederberg, January 31, 1977 ABSTRACT One S. aureus plasmid coding for tetracycline resistance, pT 127, and four plasmids (pC194, pC221, pC223, and pUB1I12) coding for chloramphenicol resistance have been in- troduced by transformation into B, subtilis. The plasmids rep- licate in—and confer antibiotic resistance upon—their new host. These experiments show that the potential for genetic ex- change between diverse bacterial species is greater than has been commonly assumed. Most of the plasmids studied so far have a narrow host range. Some, however, can replicate in a wider host range. For ex- ample, plasmid RP4 from Pseudomonas aeruginosa can be transferred to other Gram-negative bacteria such as Escherichia coli, Salmonella typhimurium, Klebsiella aerogenes, Rhizo- bium leguminosarum, and Agrobacterium tumefaciens (1). Another instance of plasmid-replicon transfer among bac- terial species, perhaps even more widely separated, is reported in this work. Five Staphylococcus aureus plasmids, coding for tetracycline or chloramphenicol resistance, have been intro- duced by direct DNA transformation into Bacillus subtilis. The plasmids can replicate and express their genetic information (antibiotic resistance) in this new host. MATERIALS AND METHODS Bacterial Strains. S. aureus strains used were SA231 (pC194) Cm', RN154 (pC223) Cm*, RN1305 (pC221) Cm", RN1777 (pS177) Sm, RN1801 (pT127) Te", RN1953 (pK545) Km*/ Nm’, and RN2438 (pUB112) Cm' from R. Novick (2). B. sub- tilis strains SB634 thy~ aroB tyr-1 and SB748 his-2 trypC2 thy~, derived from $B168, are from the Stanford collection. Media. B. subtilis was grown in L and Penassay liquid media. Resistant bacteria were selected on L-agar plates sup- plemented with antibiotics [tetracycline (Tc), 15 ug/ml; chlo- ramphenical (Cm), 5 ug/ml; streptomycin (Sm), 30 ug/ml; kanamycin (Km), 3 ug/ml] S. aureus cells were grown in CY liquid media or on GL-agar plates (3). DNAs and Enzymes. Plasmid DNAs were prepared from S. aureus strains essentially as described by Novick (2). Low-salt lysates of stationary phase cultures were clarified by centrifu- gation, concentrated with polyethylene glycol (molecular weight; 6000), and centrifuged to equilibrium in CsCl density gradients containing ethidium bromide. Cleared lysis treatment of B. subtilis strains was essentially as described for E. coli (4). Lysates were then processed similarly to the S. aureus ones (see above). EcoRI endonuclease and T4 ligase were purified and used as described (5, 6). HindIIS was a commercial preparation (BioLabs). Abbreviations: Tc, tetracycline, Cm, chloramphenicol; Sm, strepto- mycin; Km, kanamycin; Nm, neomycin. * Present address: Institut de Biologie Moléculaire, Faculté de Science, 2, pl. Jussieu, Paris 75005, France. 1680 Transformation Procedure. Induction of competence and transformation of B. subtilis were as described (7). Electrophoresis and Electron Microscopy. Horizontal agarose slab gels were used as described (8). Electron micros- copy was also performed (9). RESULTS Tetracycline resistance plasmid pT127 S. aureus strain RN1801 carries the plasmid pT127 that confers tetracycline resistance on its host (3). The plasmic DNA can transform B. subtilis strains to tetracycline resistance: 10° cells of SB634 (competence level 0.2%) exposed to 0.1 ug of pT 127 DNA yielded 10 Tc! colonies. No colonies were observed if ei- ther the cells or the DNA was omitted. The typical appearance and phenotypic match of the SB634 parent strain, auxotrophic thy~aroB~ tyr, to the Tc’ colonies confirmed that the colonies were B. subtilis. The level of resistance of the transformants was higher than 25 ug/ml in L-broth, although at concentrations above 15 ug/ml some inhibition of growth could be seen. The parental B. subtilis strain is inhibited by 5 ug/ml of Tc. Resistance was found to be a stable trait: growth for some 20 generations in liquid medium devoid of antibiotic, followed by plating on the solid medium of the same type, resulted in less than 2% ob- served colonies sensitive to tetracycline, as revealed by rep- lica-plating on medium supplemented with the drug. One of the Tc colonies was chosen for further study. A profile of the cesium chloride/ethidium bromide density gra- dient for its cleared lysis supernatant is displayed in Fig. 1. Two peaks of radioactivity can be seen. Identically treated parental Tc cells yielded only the lower density peak (Fig. 1) composed of linear DNA molecules. The heavier peak, detected in the extract of Tc" transfor- mants, contains supercoiled circular DNA molecules, as re- vealed by electron microscopy. These match the pT127 DNA molecules extracted from S. aureus, by the following criteria: (i) the two intact circular DNA preparations have identical electrophoretic mobilities; (ii) they are both resistant to EcoRI endonuclease and are cleaved by the HindIII nuclease into three matching segments. These data are displayed in Fig. 2. Equivalence of the two DNA preparations was verified by further genetic tests: two B. subtilis strains, SB634 and SB748, were transformed to tetracycline resistance with the DNA isolated from the Tc Bacillus colonies, as well as with the pT 127 DNA isolated from S. aureus. Chloramphenicol resistance plasmids Four S. aureus Cm" plasmids (pC194, pC221, pC223, and pUB112) were tested for their ability to transform B. subtilis to chloramphenicol resistance. The results were similar to those described for the Tc" plasmid, above. Genetics: Ehrlich | T 10,000 |- tt 4 e E : ° 5,000- , 4 rr 8 e \ e | . | \f 5 é e.e/ Ne 3b Leeeestoccocas | 0 10 20 Fraction number FIG. 1. Cesium chloride/ethidium bromide gradient of B. subtilis cleared lysates. We used a cleared-lysis procedure (see Materials and Methods) on 200 ml of a tritium-labeled B. subtilis culture (1 «Ci of |’H]thymidine per ml). The concentrated supernatant was centri- fuged for 36 hr at 386,000 rpm in a Spinco 50 rotor. Tubes were punc- tured at the bottom, and 0.22-ml fractions were collected. A 5-,l ali- quot of each fraction was assayed for radioactivity. The solid line corresponds to a Tc’ transformant; dashed line corresponds to the parental strain. Density increases from right to left. Specific activity of DNA was 5000 cpm/ug. (i) B. subtilis transformants resistant to 50 ug/ml of chlor- amphenicol (parental strains are sensitive to 5 wg/ml) were obtained at about the same frequency as the Tc" transformants, upon exposing competent cells to plasmid DNAs. Growth without antibiotic for 20 generations led to the loss of resistance in less then 2% of cells transformed with pC194, about 10% in those transformed with pUB112, and about 20% for the other two plasmids. (ii) Cm* transformants contain plasmid DNA indistin- guishable from that isolated from the corresponding S. aureus strains as indicated by (a) electrophoretic mobility of intact DNAs and (b) response toward EcoRI and HindIIl restriction enzymes. The number of restriction sites detected in various plasmids is indicated in Table 1, together with their molecular weights. (iii) Plasmid DNAs isolated from the transformed B. subtilis cells carry the information specifying chloramphenicol resis- tance and can transform other B. subtilis cells for the same genetic determinant. Streptomycin and kanamycin/neomycin plasmids The results obtained with pS177Sm‘ and pK545Km'-Nm‘ plasmids differ from those obtained with the Tc’ and Cm". We Table 1. Resistance markers, size, and HindIII sites of S. aureus plasmids* Resistance M,,* No. of Plasmid marker millions Hindlil sites pC194 Cm 1.8 1 pC221 Cm 3.0 1 pC223 Cm 3.0 i pUBI12 Cm 3.0 1 pT127 Te 2.9 3 * None of the plasmids has an EcoRI-sensitive site. * From Novick (2) and confirmed here by comparing cleaved DNAs with the B. subtilis phage Phi-3-T EcoRI segments (5). M,, mo- lecular weight. } Sizes of the segments are 1.5, 0.9, and 0.4 million, respectively. Proc. Natl. Acad. Sci. USA 74 (1977) 1681 Fig. 2. A, C. and E contain DNA extracted from S. aureus; lanes B, D, and F contain DNA from B. subtilis. Untreated DNA is in lanes A and B. EcoRI-treated DNA in lanes C and D, and HindIll-cleaved DNA is in lanes E and F. Agarose gel electrophoresis of plasmid pT 127 DNA. Lanes did not observe B. subtilis transformants resistant to strepto- mycin or kanamycin. A number of explanations could be put forward—these plasmids might fail to replicate or to express their genetic information in the new host. Alternatively, a particular regimen of selection might be required to detect the transformants, because in both cases B. subtilis colonies resistant to antibiotic, due to endogenous mutations, were observed at a frequency of about 1077 for Km, 1076 for Sm. Efficiency of transformation of B. subtilis with plasmid DNAs B. subtilis strains of competence greater than 0.1% could be transformed with S. aureus plasmids at an efficiency of about 10-° colonies per genome equivalent, that is, close to 100 colonies per ug of DNA. Colonies per genome equivalent are expressed on the basis of input DNA. (Under the conditions of 1682 Genetics: Ehrlich these experiments only a small fraction of the DNA is taken up.) The efficiency increased some 50 times, approaching the level of 1077 colonies per genome equivalent (10* colonies per ug of DNA) with plasmids isolated from transformed B. subtilis cells. Less than 0.5% of the efficiency remained after cleavage of plasmid DNAs with the HindIII restriction endonuclease. Treatment of cleaved DNAs with T4 ligase, resulting in about 50% recircularization (as revealed by electron microscopy in- spection), restored 30-50% of the original efficiency for Cm" plasmids, and less than 0.2% for the Tc" one. DISCUSSION The experiments reported here indicate that (i) B. stbtilis strains can be transformed to antibiotic resistance with S, aureus plasmid DNAs; (ii) the transformants acquire plasmid DNA; (iii) this DNA is indistinguishable from the S. aureus plasmid DNA by criteria of size, restriction enzyme pattern, and genetic information. This evidence shows that S. aureus plasmids can replicate and be expressed in B. subtilis. The five S. aureus plasmids introduced in B. subtilis can be subdivided into three groups: Tc" (pT127), Cm" small (pC194) and Cm! large (pC221, pC223, and pUB112, Table 1). Data reported by Novick (3) indicate that the three plasmids of the last group are not identical: they respond differently to various treatments which induce relaxation of supercoiled plasmid- protein complexes. It appears therefore that at least five dif- ferent S. aureus plasmids can be maintained in B. subtilis. The efficiency of interspecies transformation described here is high enough to allow the process to be demonstrated easily in the laboratory by employing competent cells and plasmid DNA. Hind Il restriction endonuclease cleavage of the plasmids decreases their biological activity to < 0.5%. This might be due to the possible presence of the restriction site within the gene coding for the antibiotic resistance and/or to the destruction of the circular structure of the plasmids necessary for their replication in the host. Another plasmid, pFT23, a hybrid be- tween the pSC101 replicon and the thy gene of the B. subtilis phage Phi-3-T, did not lose any transforming efficiency when Proc. Natl. Acad. Sci. USA 74 (1977} made linear by the action of Bam endonuclease (5). In that case, circular structure was not obligatory because the transforming thy gene could be integrated into another replicating structure: the chromosome of the host. Ligation of the cleaved Cm" plasmids almost fully restored their biological activity, whereas the Tc’ plasmid was not reactivated, presumably because of a lower probability of correct reassembly of the three HindIII segments. S. aureus plasmids introduced into B. subtilis are promising vectors for cloning in this new host because of their small size, easily selectable markers, and a small number of cleavage sites for certain restriction enzymes. The demonstration that replicating plasmids are shared among species of bacteria as widely diverse as Staphylococcus and Bacillus, or Escherichia and Agrobacterium |P. aeruginosa plasmid RP4, (1}| makes it likely that plasmid sharing occurs commonly in nature. This is pertinent to our views of natural microbial evolution and, in turn, to the uniqueness of con- structing DNA recombinants in the laboratory, which is a premise of much policy discussion. I gratefully acknowledge interest, criticisms and support of Dr. J. Lederberg, in whose laboratory these investigations were performed. Dr. R. Novick kindly provided S. aureus strains. The work was sup- ported by National Institutes of Health Grant 3RO1 CA 16896-18 and National Aeronautics and Space Administration Grant NGR-05- 020-004S17 to Dr. J. Lederberg. Chakrabarty, A. M. (1976) Annu. Rev. Genet. 10, 7-30. Novick, R. (1976) J. Bacteriol. 127, 1177-1187. Novick, R. P. & Brodsky, R. (1972) J. Mol. Biol. 68, 285-302. Clewell, D. B. & Helinski, D. R. (1970) Proc. Natl. Acad. Sei. USA, 62, 1159-1166. 5. Ehrlich, $. D., Bursztyn-Pettegrew, H., Stroynowski, I. & Lederberg, J. (1976) Proc. Natl. Acad. Sci. USA 73, 4145-4149. 6. Sgaramella, V., Bursztyn-Pettegrew, H. & Ehrlich, $. D. (1977) Proc. X Miles Symposium, in press. Stewart, C. (1969) J. Bacteriol. 98, 1239-1247. Harris- Warrick, R., Elkana, Y., Ehrlich, $. D. & Lederberg, J. (1975) Proc. Natl. Acad. Sci. USA 72, 2207-2211. 9. Sgaramella V., Ehrlich, S. D.. & Lederberg, J. (1976) J. Mol. Biol. 105, 603-609. BONE ~1 oe